FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890180104> ?p ?o ?g. }

• W2890180104 endingPage "303" @default.
• W2890180104 startingPage "290" @default.
• W2890180104 abstract "Background: Head and neck squamous cell carcinoma (HNSCC) is the most common malignant cancer occurring in the head and neck area, approximately 90% of the cases. Even in the cases of primary radical treatment (surgical, concomitant chemoradiotherapy or radiotherapy alone), subsequent local recurrence or distant metastases are often observed. In patients with recurrent disease who are unable to receive radical treatment, the results of palliative chemotherapy are not satisfactory. In this review, we summarized the standard treatment options, current development of new drugs and future perspectives in the treatment of patients with recurrent locally advanced and/or metastatic HNSCC. Methods: PubMed databases with words ‘head and neck cancer treatment’, ‘immunotherapy in head and neck cancer treatment’ were searched and yielded 186512 and 2249 papers respectively. We selected the most cited articles and reports presenting new immunotherapy agents and drug combinations in HNSCC. Results: Recently, two new agents been approved in the treatment of recurrent locally advanced and/or metastatic HNSCC. These are immune-checkpoint inhibitors targeting PD1 (nivolumab and pembrolizumab) which are the most active drugs in the second line treatment of advanced HNSCC. Still, the first line ‘golden standard’ is the chemotherapy regimen (cisplatin, 5-fluorouracyl) combined with cetuximab. Many phase 3 studies are currently ongoing, evaluating the efficacy of combinational treatment-anti-CTLA4 with anti-PD1 or anti-PDL1. Very encouraging results have been shown in early phase studies evaluating the combination of immunecheckpoint inhibitors with tumor microenvironment immunosuppressive inhibitors. Conclusion: Despite the huge progress in the systemic treatment of patients with recurrent locally advanced and/or metastatic HNSCC, the disease at this stage remains incurable. Undoubtedly, further research in the field of biomarkers for effective immunotherapy is needed in order to select a group of patients whose will benefit from this therapy, as the treatment is still ineffective in most patients." @default.
• W2890180104 created "2018-09-27" @default.
• W2890180104 creator A5005706056 @default.
• W2890180104 creator A5011901659 @default.
• W2890180104 creator A5036859870 @default.
• W2890180104 creator A5050927742 @default.
• W2890180104 creator A5065544926 @default.
• W2890180104 creator A5071937365 @default.
• W2890180104 date "2019-06-25" @default.
• W2890180104 modified "2023-10-15" @default.
• W2890180104 title "Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck" @default.
• W2890180104 cites W1883079188 @default.
• W2890180104 cites W1930879408 @default.
• W2890180104 cites W1952422131 @default.
• W2890180104 cites W1964589324 @default.
• W2890180104 cites W1967668939 @default.
• W2890180104 cites W1978068596 @default.
• W2890180104 cites W1984545852 @default.
• W2890180104 cites W1986241711 @default.
• W2890180104 cites W1988596206 @default.
• W2890180104 cites W1995992733 @default.
• W2890180104 cites W2007553857 @default.
• W2890180104 cites W2018873263 @default.
• W2890180104 cites W2035576607 @default.
• W2890180104 cites W2040499562 @default.
• W2890180104 cites W2051120695 @default.
• W2890180104 cites W2053353274 @default.
• W2890180104 cites W2066671159 @default.
• W2890180104 cites W2070059266 @default.
• W2890180104 cites W2084284769 @default.
• W2890180104 cites W2094530868 @default.
• W2890180104 cites W2101027485 @default.
• W2890180104 cites W2101653483 @default.
• W2890180104 cites W2104810134 @default.
• W2890180104 cites W2105499277 @default.
• W2890180104 cites W2112601576 @default.
• W2890180104 cites W2112845420 @default.
• W2890180104 cites W2118471749 @default.
• W2890180104 cites W2118991777 @default.
• W2890180104 cites W2127468351 @default.
• W2890180104 cites W2128758225 @default.
• W2890180104 cites W2136871952 @default.
• W2890180104 cites W2146906100 @default.
• W2890180104 cites W2149807823 @default.
• W2890180104 cites W2153991063 @default.
• W2890180104 cites W2154610258 @default.
• W2890180104 cites W2156071539 @default.
• W2890180104 cites W2158731226 @default.
• W2890180104 cites W2162117731 @default.
• W2890180104 cites W2166662937 @default.
• W2890180104 cites W2169386895 @default.
• W2890180104 cites W2263759961 @default.
• W2890180104 cites W2279794760 @default.
• W2890180104 cites W2323145611 @default.
• W2890180104 cites W2523194272 @default.
• W2890180104 cites W2535284666 @default.
• W2890180104 cites W2589751944 @default.
• W2890180104 cites W2595109242 @default.
• W2890180104 cites W2602907503 @default.
• W2890180104 cites W2606976048 @default.
• W2890180104 cites W2672265346 @default.
• W2890180104 cites W2675354485 @default.
• W2890180104 cites W2732229964 @default.
• W2890180104 cites W2739488327 @default.
• W2890180104 cites W2747016053 @default.
• W2890180104 cites W2762460629 @default.
• W2890180104 cites W2794244726 @default.
• W2890180104 cites W2806431043 @default.
• W2890180104 cites W3011071920 @default.
• W2890180104 doi "https://doi.org/10.2174/1871520618666180910092356" @default.
• W2890180104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30198439" @default.
• W2890180104 hasPublicationYear "2019" @default.
• W2890180104 type Work @default.
• W2890180104 sameAs 2890180104 @default.
• W2890180104 citedByCount "13" @default.
• W2890180104 countsByYear W28901801042019 @default.
• W2890180104 countsByYear W28901801042020 @default.
• W2890180104 countsByYear W28901801042021 @default.
• W2890180104 countsByYear W28901801042023 @default.
• W2890180104 crossrefType "journal-article" @default.
• W2890180104 hasAuthorship W2890180104A5005706056 @default.
• W2890180104 hasAuthorship W2890180104A5011901659 @default.
• W2890180104 hasAuthorship W2890180104A5036859870 @default.
• W2890180104 hasAuthorship W2890180104A5050927742 @default.
• W2890180104 hasAuthorship W2890180104A5065544926 @default.
• W2890180104 hasAuthorship W2890180104A5071937365 @default.
• W2890180104 hasConcept C121608353 @default.
• W2890180104 hasConcept C126322002 @default.
• W2890180104 hasConcept C143998085 @default.
• W2890180104 hasConcept C2776530083 @default.
• W2890180104 hasConcept C2776694085 @default.
• W2890180104 hasConcept C2776833033 @default.
• W2890180104 hasConcept C2777701055 @default.
• W2890180104 hasConcept C2778424827 @default.
• W2890180104 hasConcept C2779998722 @default.
• W2890180104 hasConcept C2780030458 @default.
• W2890180104 hasConcept C2780057760 @default.
• W2890180104 hasConcept C2781413609 @default.

• next